Cargando…

Alpha-synuclein oligomers: a new hope

Alpha-synuclein is a protein implicated in Parkinson’s disease and thought to be one of the main pathological drivers in the disease, although it remains unclear how this protein elicits its neurotoxic effects. Recent findings indicate that the assembly of toxic oligomeric species of alpha-synuclein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bengoa-Vergniory, Nora, Roberts, Rosalind F., Wade-Martins, Richard, Alegre-Abarrategui, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663814/ https://www.ncbi.nlm.nih.gov/pubmed/28803412 http://dx.doi.org/10.1007/s00401-017-1755-1

Ejemplares similares

Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson’s disease brain
por: Roberts, Rosalind F., et al.
Publicado: (2015)

Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
por: Fields, Carroll Rutherford, et al.
Publicado: (2019)

Detection of alpha‐synuclein conformational variants from gastro‐intestinal biopsy tissue as a potential biomarker for Parkinson's disease
por: Ruffmann, C., et al.
Publicado: (2018)

Selective vulnerability in α-synucleinopathies
por: Alegre-Abarrategui, Javier, et al.
Publicado: (2019)

Beyond Strains: Molecular Diversity in Alpha-Synuclein at the Center of Disease Heterogeneity
por: Wojewska, Marcelina J., et al.
Publicado: (2023)

Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer’s disease
por: Bengoa-Vergniory, Nora, et al.
Publicado: (2021)

Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles
por: Doucet, Marika, et al.
Publicado: (2017)

Lighting Up Alpha-synuclein Oligomers
por: Richter, Franziska
Publicado: (2018)

Direct detection of alpha synuclein oligomers in vivo
por: Dimant, Hemi, et al.
Publicado: (2013)

Exosomal cell-to-cell transmission of alpha synuclein oligomers
por: Danzer, Karin M, et al.
Publicado: (2012)

Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers
por: Vaikath, Nishant, et al.
Publicado: (2022)

Impairment of Macroautophagy in Dopamine Neurons Has Opposing Effects on Parkinsonian Pathology and Behavior
por: Hunn, Benjamin H.M., et al.
Publicado: (2019)

Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes
por: Gustafsson, Gabriel, et al.
Publicado: (2017)

Unconventional secretion of α-synuclein mediated by palmitoylated DNAJC5 oligomers
por: Wu, Shenjie, et al.
Publicado: (2023)

Temperature-Dependent Structural Changes of Parkinson's Alpha-Synuclein Reveal the Role of Pre-Existing Oligomers in Alpha-Synuclein Fibrillization
por: Ariesandi, Winny, et al.
Publicado: (2013)

Striatal Dopamine Transporter Function Is Facilitated by Converging Biology of α-Synuclein and Cholesterol
por: Threlfell, Sarah, et al.
Publicado: (2021)

Mutation of Tyrosine Sites in the Human Alpha-Synuclein Gene Induces Neurotoxicity in Transgenic Mice with Soluble Alpha-Synuclein Oligomer Formation
por: Lassen, Louise Berkhoudt, et al.
Publicado: (2022)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
por: Du, Xiao-yu, et al.
Publicado: (2020)

DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function
por: Plotegher, N., et al.
Publicado: (2017)

Polymorphism in alpha-synuclein oligomers and its implications in toxicity under disease conditions
por: Yoo, Je Min, et al.
Publicado: (2022)

Polymorphic Alpha-Synuclein Oligomers: Characterization and Differential Detection with Novel Corresponding Antibodies
por: Moore, Kenya, et al.
Publicado: (2023)

Alpha-synuclein oligomers alter the spontaneous firing discharge of cultured midbrain neurons
por: Tomagra, Giulia, et al.
Publicado: (2023)

α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies
por: Bigi, Alessandra, et al.
Publicado: (2023)

Alpha-Synuclein Oligomers—Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders
por: Ingelsson, Martin
Publicado: (2016)

Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
por: Sekiya, Hiroaki, et al.
Publicado: (2022)

Corrigendum: Alpha-synuclein oligomers alter the spontaneous firing discharge of cultured midbrain neurons
por: Tomagra, Giulia, et al.
Publicado: (2023)

Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson’s iPSC-derived dopamine neurons
por: Zambon, Federico, et al.
Publicado: (2019)

Modelling Ser129 Phosphorylation Inhibits Membrane Binding of Pore-Forming Alpha-Synuclein Oligomers
por: Nübling, Georg Sebastian, et al.
Publicado: (2014)

Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson’s Disease Etiopathology
por: Wilkaniec, Anna, et al.
Publicado: (2018)

Endogenous alpha-synuclein monomers, oligomers and resulting pathology: let’s talk about the lipids in the room
por: Killinger, Bryan A., et al.
Publicado: (2019)

Alpha-synuclein oligomers and small nerve fiber pathology in skin are potential biomarkers of Parkinson’s disease
por: Vacchi, Elena, et al.
Publicado: (2021)

Quantifying Co-Oligomer Formation by α-Synuclein
por: Iljina, Marija, et al.
Publicado: (2018)

Stabilization of α-synuclein oligomers using formaldehyde
por: Ruesink, Harm, et al.
Publicado: (2019)

Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease
por: Deas, Emma, et al.
Publicado: (2016)

Age-related increase of alpha-synuclein oligomers is associated with motor disturbances in L61 transgenic mice
por: Roshanbin, Sahar, et al.
Publicado: (2021)

The alpha-synuclein oligomers activate nuclear factor of activated T-cell (NFAT) modulating synaptic homeostasis and apoptosis
por: Sant’Anna, Ricardo, et al.
Publicado: (2023)

Optical Structural Analysis of Individual α‐Synuclein Oligomers
por: Varela, Juan A., et al.
Publicado: (2018)

Mapping Surface Hydrophobicity of α-Synuclein Oligomers at the Nanoscale
por: Lee, Ji-Eun, et al.
Publicado: (2018)

Conformational distortion in a fibril-forming oligomer arrests alpha-Synuclein fibrillation and minimizes its toxic effects
por: Chakraborty, Ritobrita, et al.
Publicado: (2021)

Gastrointestinal Immunity and Alpha-Synuclein
por: Barbut, Denise, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_krcqm44d5jiijan2p54gebp9f1